News summary

Half of tested antiaging products moved nothing in new study

Source: Longevity Technology • Published: 16 Sept 2026, 17:04

Summarized by Masters of Longevity from Longevity Technology.

A Yale-led meta-analysis harmonized 51 intervention studies and standardized epigenetic clock outputs to assess whether interventions change DNA methylation aging measures.

Half of tested antiaging products moved nothing in new study
Key Takeaways
  • Pooling 51 studies and 3,128 blood samples, researchers calculated 16 epigenetic clocks and 94 methylation biomarkers using one pipeline.
  • Thirteen interventions still showed significant decreases after multiple-testing correction, while 26 interventions showed no significant change and five increased age.
  • Senolytic interventions lacked reproducible, directionally consistent effects across biomarkers and studies, failing the authors' reproducibility criteria.
Read the full article at Longevity Technology

Continue exploring

Recommended MoL Picks

MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.